未登录

N

Natalia Słabisz

Wroclaw University of Science and Technology

H指数:4

被引数:37

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

更正：对产NDM酶肺炎克雷伯菌临床分离株在体外对新纳入感染治疗方案中的新抗生素的敏感性评估

Frontiers in Microbiology

IF4.5

2026-01-010

OAAI

Carbapenem-Resistant Acinetobacter baumannii: Treatment, PK/PD Considerations, and Emerging Strategies

碳青霉烯耐药鲍曼不动杆菌：治疗、药代动力学/药效学考量及新兴策略

IF3.3

2026-01-010

OA

Fungal Infection in HIV-Infected Patients—Is It Still a Challenge?

HIV感染者中的真菌感染——这仍然是挑战吗？

Journal of Clinical Medicine 2025, Vol. 14, Page 8570

IF2.9

2025-12-030

OAAI

A Retrospective Observational Analysis of Factors Determining the Formation of Pressure Ulcers in ICU Patients Treated for COVID-19

对接受COVID-19治疗的ICU患者压力性溃疡形成影响因素的回顾性观察分析

inflammation research

IF4.1

2025-08-290

OA

Old Bug-New Challenges After COVID-19 Pandemic: Severe Invasive Streptococcus pyogenes Infections in Adults-A Single-Center Experience in Poland

老虫子-新型冠状病毒肺炎大流行后的新挑战: 成人严重的侵袭性化脓性链球菌感染-波兰的单中心经验

IF3.3

2025-02-170

OAAI

Assessing the Interpretation of Molecular Test Results in the Diagnosis of Bloodstream Infections

IF3.3

2024-04-272

OA

Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

评估产生NDM的肺炎克雷伯菌临床分离株对感染治疗方案中包括的新抗生素的体外敏感性

FRONTIERS IN MICROBIOLOGY

IF4.5

2024-04-052

OAAI

How to Defeat Multidrug-Resistant Bacteria in Intensive Care Units. A Lesson from the COVID-19 Pandemic Prevention, Reservoirs, and Implications for Clinical Practice .

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

IF3.2

2024-01-011

OAAI

Impact of the COVID-19 Pandemic on the Epidemiology of Bloodstream Infections in Hospitalized Patients-Experience from a 4th Military Clinical Hospital in Poland

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-09-133

OAAI